Dmitriy Zak, MD | |
639 Hospital Dr, Mountain Home, AR 72653-2914 | |
(479) 587-1700 | |
(479) 587-1366 |
Full Name | Dmitriy Zak |
---|---|
Gender | Male |
Speciality | Medical Oncology |
Experience | 30 Years |
Location | 639 Hospital Dr, Mountain Home, Arkansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548371289 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Baxter Regional Medical Center | Mountain home, AR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Highlands Oncology Group Pa | 7416976196 | 63 |
News Archive
Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration of Desoximetasone Ointment USP 0.25%, the generic equivalent of Topicort Ointment, 0.25%, of Taro Pharmaceuticals U.S.A., Inc.
A University of Colorado Cancer Center study published online ahead of print in the journal Nutrition and Cancer describes the laboratory synthesis of the most active component of grape seed extract, B2G2, and shows this synthesized compound induces the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed.
When treating skin cancer, differentiating between melanoma and healthy moles can be difficult. Doctors must know the shape of the cancer and how deep it is before treating the problem. Now, a skin care specialist at the University of Missouri-Columbia has teamed with MU engineering and internal medicine professors to develop a better identification and treatment process.
Structural biology research conducted at the U.S. Department of Energy's SLAC National Accelerator Laboratory has uncovered how small insecticidal protein crystals that are naturally produced by bacteria might be tailored to combat dengue fever and the Zika virus.
Nasal saline and corticosteroid sprays are pretty standard treatment for individuals battling chronic rhinosinusitis.
› Verified 3 days ago
Entity Name | Highlands Oncology Group Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346211323 PECOS PAC ID: 7416976196 Enrollment ID: O20051111000204 |
News Archive
Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration of Desoximetasone Ointment USP 0.25%, the generic equivalent of Topicort Ointment, 0.25%, of Taro Pharmaceuticals U.S.A., Inc.
A University of Colorado Cancer Center study published online ahead of print in the journal Nutrition and Cancer describes the laboratory synthesis of the most active component of grape seed extract, B2G2, and shows this synthesized compound induces the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed.
When treating skin cancer, differentiating between melanoma and healthy moles can be difficult. Doctors must know the shape of the cancer and how deep it is before treating the problem. Now, a skin care specialist at the University of Missouri-Columbia has teamed with MU engineering and internal medicine professors to develop a better identification and treatment process.
Structural biology research conducted at the U.S. Department of Energy's SLAC National Accelerator Laboratory has uncovered how small insecticidal protein crystals that are naturally produced by bacteria might be tailored to combat dengue fever and the Zika virus.
Nasal saline and corticosteroid sprays are pretty standard treatment for individuals battling chronic rhinosinusitis.
› Verified 3 days ago
Entity Name | Baxter County Regional Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265899363 PECOS PAC ID: 3274420971 Enrollment ID: O20160420000345 |
News Archive
Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration of Desoximetasone Ointment USP 0.25%, the generic equivalent of Topicort Ointment, 0.25%, of Taro Pharmaceuticals U.S.A., Inc.
A University of Colorado Cancer Center study published online ahead of print in the journal Nutrition and Cancer describes the laboratory synthesis of the most active component of grape seed extract, B2G2, and shows this synthesized compound induces the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed.
When treating skin cancer, differentiating between melanoma and healthy moles can be difficult. Doctors must know the shape of the cancer and how deep it is before treating the problem. Now, a skin care specialist at the University of Missouri-Columbia has teamed with MU engineering and internal medicine professors to develop a better identification and treatment process.
Structural biology research conducted at the U.S. Department of Energy's SLAC National Accelerator Laboratory has uncovered how small insecticidal protein crystals that are naturally produced by bacteria might be tailored to combat dengue fever and the Zika virus.
Nasal saline and corticosteroid sprays are pretty standard treatment for individuals battling chronic rhinosinusitis.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dmitriy Zak, MD 639 Hospital Dr, Mountain Home, AR 72653-2914 Ph: (917) 671-7938 | Dmitriy Zak, MD 639 Hospital Dr, Mountain Home, AR 72653-2914 Ph: (479) 587-1700 |
News Archive
Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration of Desoximetasone Ointment USP 0.25%, the generic equivalent of Topicort Ointment, 0.25%, of Taro Pharmaceuticals U.S.A., Inc.
A University of Colorado Cancer Center study published online ahead of print in the journal Nutrition and Cancer describes the laboratory synthesis of the most active component of grape seed extract, B2G2, and shows this synthesized compound induces the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed.
When treating skin cancer, differentiating between melanoma and healthy moles can be difficult. Doctors must know the shape of the cancer and how deep it is before treating the problem. Now, a skin care specialist at the University of Missouri-Columbia has teamed with MU engineering and internal medicine professors to develop a better identification and treatment process.
Structural biology research conducted at the U.S. Department of Energy's SLAC National Accelerator Laboratory has uncovered how small insecticidal protein crystals that are naturally produced by bacteria might be tailored to combat dengue fever and the Zika virus.
Nasal saline and corticosteroid sprays are pretty standard treatment for individuals battling chronic rhinosinusitis.
› Verified 3 days ago
Dr. James C Croom, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 230 Highway 5 N Ste 20, Mountain Home, AR 72653 Phone: 870-425-6212 Fax: 870-508-6896 | |
Daniel Pesek Valach, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1409 Highway 201 N, Suite 1, Mountain Home, AR 72653 Phone: 870-508-5010 Fax: 870-508-5020 | |
Dr. Raymond L. Bandy, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 628 Hospital Dr Ste 3-e, Mountain Home, AR 72653 Phone: 870-508-7450 Fax: 870-508-7768 | |
Dr. Mark D West, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-508-1000 | |
Dr. Lincoln Alexander Godfrey, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-501-1000 Fax: 870-424-3089 | |
Dr. William Stephen Dyer, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 228 Bucher Dr, Mountain Home, AR 72653 Phone: 870-425-4416 Fax: 870-425-8615 | |
Dr. Richard D Schmidt, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-508-1000 Fax: 870-424-3089 |